Osaic Holdings’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.46K | Buy |
520
+165
| +46% | +$781 | ﹤0.01% | 6419 |
|
|
2025
Q1 | $1.63K | Buy |
355
+34
| +11% | +$156 | ﹤0.01% | 6538 |
|
|
2024
Q4 | $1.54K | Sell |
321
-147
| -31% | -$704 | ﹤0.01% | 6563 |
|
|
2024
Q3 | $2.19K | Sell |
468
-15,871
| -97% | -$74.4K | ﹤0.01% | 6407 |
|
|
2024
Q2 | $92.3K | Buy |
16,339
+9,184
| +128% | +$51.9K | ﹤0.01% | 4190 |
|
|
2024
Q1 | $29.4K | Sell |
7,155
-7,498
| -51% | -$30.8K | ﹤0.01% | 5087 |
|
|
2023
Q4 | $61.8K | Buy |
14,653
+4,425
| +43% | +$18.7K | ﹤0.01% | 4763 |
|
|
2023
Q3 | $44.2K | Buy |
10,228
+3,271
| +47% | +$14.1K | ﹤0.01% | 5066 |
|
|
2023
Q2 | $45.8K | Buy |
6,957
+590
| +9% | +$3.89K | ﹤0.01% | 4991 |
|
|
2023
Q1 | $43.2K | Buy |
6,367
+1,932
| +44% | +$13.1K | ﹤0.01% | 5046 |
|
|
2022
Q4 | $32K | Sell |
4,435
-370
| -8% | -$2.67K | ﹤0.01% | 5243 |
|
|
2022
Q3 | $47K | Sell |
4,805
-730
| -13% | -$7.14K | ﹤0.01% | 4954 |
|
|
2022
Q2 | $60K | Buy |
5,535
+162
| +3% | +$1.76K | ﹤0.01% | 4816 |
|
|
2022
Q1 | $62K | Buy |
5,373
+429
| +9% | +$4.95K | ﹤0.01% | 4935 |
|
|
2021
Q4 | $78K | Buy |
4,944
+572
| +13% | +$9.02K | ﹤0.01% | 4789 |
|
|
2021
Q3 | $74K | Buy |
4,372
+30
| +0.7% | +$508 | ﹤0.01% | 4789 |
|
|
2021
Q2 | $93K | Buy |
4,342
+523
| +14% | +$11.2K | ﹤0.01% | 4537 |
|
|
2021
Q1 | $58K | Buy |
3,819
+467
| +14% | +$7.09K | ﹤0.01% | 4773 |
|
|
2020
Q4 | $44K | Buy |
3,352
+626
| +23% | +$8.22K | ﹤0.01% | 4618 |
|
|
2020
Q3 | $29K | Sell |
2,726
-1,006
| -27% | -$10.7K | ﹤0.01% | 4676 |
|
|
2020
Q2 | $43K | Buy |
3,732
+1,122
| +43% | +$12.9K | ﹤0.01% | 4278 |
|
|
2020
Q1 | $28K | Buy |
+2,610
| New | +$28K | ﹤0.01% | 4391 |
|